| |
| |
|
| Insider
Information: |
Treu Jesse I |
| Relationship: |
Director |
| City: |
|
| State: |
|
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
24 |
|
| Direct
Shares |
55,258 |
|
|
Indirect Shares
|
2,983,502 |
|
|
| Direct
Value |
$32,066 |
|
|
|
Indirect Value
|
$10,097,778 |
|
|
| Total
Shares |
3,038,760 |
|
|
| Total
Value |
$10,129,844 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Nuvasive Inc |
NUVA |
10% Owner |
|
0 |
2004-05-18 |
31,204 |
Premium* |
|
|
Senomyx Inc |
SNMX |
10% Owner |
|
0 |
2004-06-25 |
19,603 |
Premium* |
|
|
Santarus Inc |
SNTS |
10% Owner |
2004-04-06 |
0 |
2004-04-06 |
64,471 |
Premium* |
|
|
Somaxon Pharmaceuticals, Inc. |
SOMX |
Director |
2010-06-09 |
0 |
2009-12-18 |
0 |
Premium* |
|
|
Vanda Pharmaceuticals Inc. |
VNDA |
10% Owner |
2006-04-18 |
0 |
2006-12-12 |
21,068 |
Premium* |
|
|
Northstar Neuroscience Inc |
NSTR |
Director |
2007-05-18 |
17,231 |
2007-05-18 |
14,690 |
Premium* |
|
|
Paratek Pharmaceuticals Inc |
PRTK |
10% Owner |
2006-05-15 |
0 |
2009-01-30 |
67,875 |
Premium* |
|
|
Volcano Corp |
VOLC |
10% Owner |
2008-04-24 |
21,289 |
2008-07-16 |
62,513 |
Premium* |
|
|
Cadence Pharmaceuticals Inc |
CADX |
10% Owner |
|
0 |
2014-03-19 |
0 |
Premium* |
|
|
Orexigen Therapeutics, Inc. |
OREX |
10% Owner |
2007-11-27 |
15,096 |
2011-12-22 |
50,643 |
Premium* |
|
|
Alimera Sciences Inc |
ALIM |
10% Owner |
2010-04-27 |
0 |
2011-06-02 |
40,790 |
Premium* |
|
|
Achillion Pharmaceuticals Inc |
ACHN |
10% Owner |
|
0 |
2013-01-18 |
244,057 |
Premium* |
|
|
Zogenix, Inc. |
ZGNX |
10% Owner |
2010-11-29 |
0 |
2011-09-16 |
169,251 |
Premium* |
|
|
Clovis Oncology, Inc. |
CLVS |
10% Owner |
2011-11-21 |
0 |
2011-11-21 |
51,013 |
Premium* |
|
|
Durata Therapeutics, Inc. |
DRTX |
10% Owner |
|
0 |
2012-07-24 |
22,306 |
Premium* |
|
|
Esperion Therapeutics, Inc. |
ESPR |
10% Owner |
|
0 |
2013-07-01 |
35,253 |
Premium* |
|
|
Ocera Therapeutics Inc |
OCRX |
10% Owner |
2013-07-15 |
0 |
2013-07-15 |
1,920,730 |
Premium* |
|
|
Tobira Therapeutics Inc |
TBRA |
Director, 10% Owner |
|
0 |
2013-08-27 |
32,091 |
Premium* |
|
|
Evoke Pharma Inc |
EVOK |
10% Owner |
|
0 |
2013-09-30 |
24,256 |
Premium* |
|
|
Veracyte, Inc. |
VCYT |
Director |
2019-03-04 |
1,642 |
2019-03-04 |
1,641 |
Premium* |
|
|
Tandem Diabetes Care Inc |
TNDM |
Director, 10% Owner |
2013-11-19 |
0 |
2013-11-19 |
54,390 |
Premium* |
|
|
Dicerna Pharmaceuticals Inc |
DRNA |
10% Owner |
2014-02-04 |
0 |
2014-02-04 |
13,004 |
Premium* |
|
|
Achaogen Inc |
AKAO |
10% Owner |
2014-03-17 |
0 |
2014-03-17 |
33,890 |
Premium* |
|
|
Aldeyra Therapeutics, Inc. |
ALDX |
Director |
2019-03-26 |
0 |
2019-03-26 |
8,763 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ALDX |
Aldeyra Therapeutics, Inc... |
Director |
– • – |
2019-03-26 |
4 |
S |
$10.01 |
$968,397 |
I/I |
(96,743) |
8,763 |
0 |
- |
|
| VCYT |
Veracyte, Inc. |
Director |
– • – |
2019-03-04 |
4 |
S |
$20.21 |
$8,632,722 |
I/I |
(427,151) |
0 |
0 |
- |
|
| VCYT |
Veracyte, Inc. |
Director |
– • – |
2019-03-01 |
4 |
S |
$20.45 |
$5,623,750 |
I/I |
(275,000) |
12,193 |
0 |
- |
|
| VCYT |
Veracyte, Inc. |
Director |
– • – |
2019-02-28 |
4 |
S |
$20.44 |
$7,176,400 |
I/I |
(350,000) |
14,216 |
0 |
- |
|
| VCYT |
Veracyte, Inc. |
Director |
– • – |
2018-08-01 |
4 |
S |
$10.85 |
$1,302,000 |
I/I |
(120,000) |
16,804 |
0 |
- |
|
| VCYT |
Veracyte, Inc. |
Director |
– • – |
2018-07-31 |
4 |
S |
$10.82 |
$4,111,600 |
I/I |
(380,000) |
17,692 |
0 |
- |
|
| VCYT |
Veracyte, Inc. |
Director |
– • – |
2017-05-16 |
4 |
S |
$8.08 |
$17,986 |
I/I |
(2,226) |
20,504 |
0 |
- |
|
| VCYT |
Veracyte, Inc. |
Director |
– • – |
2017-05-16 |
4 |
A |
$0.00 |
$0 |
I/I |
1,641 |
1,641 |
0 |
- |
|
| VCYT |
Veracyte, Inc. |
Director |
– • – |
2017-05-16 |
4 |
A |
$0.00 |
$0 |
D/D |
1,642 |
1,642 |
0 |
- |
|
| VCYT |
Veracyte, Inc. |
Director |
– • – |
2017-05-16 |
4 |
D |
$0.00 |
$0 |
I/I |
(25,245) |
0 |
0 |
- |
|
| CADX |
Cadence Pharmaceuticals I... |
10% Owner |
– – • |
2014-03-19 |
4 |
D |
$14.00 |
$146,195,434 |
I/I |
(10,442,531) |
0 |
0 |
- |
|
| AKAO |
Achaogen Inc |
10% Owner |
– – • |
2014-03-17 |
4 |
A |
$0.00 |
$0 |
I/I |
2,020,939 |
33,890 |
0 |
- |
|
| DRNA |
Dicerna Pharmaceuticals I... |
10% Owner |
– – • |
2014-02-04 |
4 |
A |
$0.00 |
$0 |
I/I |
1,765,711 |
13,004 |
0 |
- |
|
| TNDM |
Tandem Diabetes Care Inc |
Director |
– • • |
2013-11-19 |
4 |
A |
$0.00 |
$0 |
I/I |
3,243,448 |
54,390 |
0 |
- |
|
| VCYT |
Veracyte, Inc. |
Director |
– • • |
2013-11-04 |
4 |
A |
$0.00 |
$0 |
I/I |
3,086,024 |
22,730 |
0 |
- |
|
| EVOK |
Evoke Pharma Inc |
10% Owner |
– – • |
2013-09-30 |
4 |
A |
$0.00 |
$0 |
I/I |
1,133,333 |
19,006 |
0 |
- |
|
| EVOK |
Evoke Pharma Inc |
10% Owner |
– – • |
2013-09-24 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
5,250 |
|
- |
|
| TBRA |
Tobira Therapeutics Inc |
Director |
– • • |
2013-08-27 |
4 |
B |
$4.00 |
$3,000,000 |
I/I |
750,000 |
2,571,117 |
2.25 |
- |
|
| TBRA |
Tobira Therapeutics Inc |
Director |
– • • |
2013-08-27 |
4 |
A |
$0.00 |
$0 |
I/I |
1,800,109 |
14,920 |
0 |
- |
|
| TBRA |
Tobira Therapeutics Inc |
Director |
– • • |
2013-08-21 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
53,099 |
|
- |
|
| OCRX |
Ocera Therapeutics Inc |
10% Owner |
– – • |
2013-07-15 |
4/A |
B |
$6.03 |
$7,999,992 |
I/I |
1,327,491 |
1,857,036 |
1.5 |
- |
|
| OCRX |
Ocera Therapeutics Inc |
10% Owner |
– – • |
2013-07-15 |
3/A |
IO |
$0.00 |
$0 |
I/I |
0 |
1,588,857 |
|
- |
|
| OCRX |
Ocera Therapeutics Inc |
10% Owner |
– – • |
2013-07-15 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
1,629,157 |
|
- |
|
| OCRX |
Ocera Therapeutics Inc |
10% Owner |
– – • |
2013-07-15 |
4 |
B |
$6.03 |
$7,999,992 |
I/I |
1,327,491 |
1,897,336 |
1.5 |
- |
|
| ESPR |
Esperion Therapeutics, In... |
10% Owner |
– – • |
2013-07-01 |
4 |
A |
$0.00 |
$0 |
I/I |
1,816,474 |
30,462 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
